Experience with Sorafenib in 3 Hospitals in Sao Paulo

Experience with Sorafenib in 3 Hospitals in Sao Paulo

Introduction and aim: Sorafenib has been the standard of care for first-line treatment of advanced hepatocellular carcinoma, a complex disease that affects an extremely heterogenous population. Thereby requiring multidisciplinary individualized treatment strategies that match the disease characteris...

Full description

Bibliographic Details
Main Authors:	Rogério Camargo-Pinheiro-Alves, Daniele E. Viera-Alves, Arthur Malzyner, Otavio Gampel, Thaisa de F. Almeida-Costa, Betty Guz, Paula Poletti
Format:	Article
Language:	English
Published:	Elsevier 2019-01-01
Series:	Annals of Hepatology
Subjects:	Child-Pugh score BCLC staging Transarterial chemoembolization Overall survival
Online Access:	http://www.sciencedirect.com/science/article/pii/S1665268119303199

Similar Items

Etiopathogenetic Factors of Hepatocellular Carcinoma, Overall Survival, and Their Evolution over Time—Czech Tertiary Center Overview
by: Petr Hříbek, et al.
Published: (2022-08-01)

Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma with Child-Pugh B7
by: Jiang JQ, et al.
Published: (2023-09-01)

BCLC-B hepatocellular carcinoma treatment or when should the systemic therapy be started
by: V. V. Breder, et al.
Published: (2018-07-01)

The priority of liver resection compared with transarterial chemoembolization in hepatocellular carcinoma at BCLC B1 stage: A single-center experience
by: Peng-Sheng Yi, et al.
Published: (2022-11-01)

Efficacy and safety of transarterial chemoembolization plus sorafenib in patients with recurrent hepatocellular carcinoma after liver transplantation
by: Xia Zhang, et al.
Published: (2023-01-01)

A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function
by: Joon Yeul Nam, et al.
Published: (2020-06-01)

Evaluation of Pretreatment Albumin–Bilirubin Grade as a Better Prognostic Factor Compared to Child–Pugh Classification in Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization Combined with Radiotherapy
by: Jason Joon Bock Lee, et al.
Published: (2023-02-01)

A refined prediction model for survival in hepatocellular carcinoma patients treated with transarterial chemoembolization
by: Hae Lim Lee, et al.
Published: (2024-03-01)

A Nomogram Based on Preoperative Lipiodol Deposition after Sequential Retreatment with Transarterial Chemoembolization to Predict Prognoses for Intermediate-Stage Hepatocellular Carcinoma
by: Xiang-Ke Niu, et al.
Published: (2022-08-01)

Ability of the ALBI grade to predict posthepatectomy liver failure and long-term survival after liver resection for different BCLC stages of HCC
by: Ze-Qun Zhang, et al.
Published: (2018-10-01)

Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study
by: Liyun Zheng, et al.
Published: (2021-01-01)

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib
by: Lei Zhang, et al.
Published: (2021-05-01)

Sorafenib with Transarterial Chemoembolization Achieves Improved Survival vs. Sorafenib Alone in Advanced Hepatocellular Carcinoma: A Nationwide Population-Based Cohort Study
by: Victor C. Kok, et al.
Published: (2019-07-01)

Locoregional Approaches in Cholangiocarcinoma Treatment
by: Alexander E. Hare, et al.
Published: (2022-11-01)

Evaluation of models to predict prognosis in patients with advanced hepatocellular carcinoma treated with TACE combined with apatinib
by: Fang Sun, et al.
Published: (2024-04-01)

Arterial chemoembolization for patients with hepatocellular carcinoma and elevated lactate dehydrogenase is associated with low survival: a cohort study
by: Genghui Zhuang, et al.
Published: (2022-06-01)

Analysis of factors affecting the prognosis of transcatheter arterial chemoembolization for hepatitis B-related hepatocellular carcinoma
by: Jiangping Cun, et al.
Published: (2021-05-01)

Chinese herbal medicine, Jianpi Ligan decoction, improves prognosis of unresectable hepatocellular carcinoma after transarterial chemoembolization: a retrospective study
by: Tang CW, et al.
Published: (2016-08-01)

Noninvasive Imaging Evaluation Based on Computed Tomography of the Efficacy of Initial Transarterial Chemoembolization to Predict Outcome in Patients with Hepatocellular Carcinoma
by: Dai Y, et al.
Published: (2022-04-01)

Role of drug-eluting beads versus conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Mahmoud Abu Elfadl, et al.
Published: (2019-01-01)

Role of triphasic computed tomography in prediction of response to transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma patients
by: Ahmed A.E Hassan Desoky, et al.
Published: (2019-01-01)

Sorafenib Combined with Chemoembolization for Locally Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion: A Propensity Score Analysis
by: Gun Ha Kim, et al.
Published: (2021-10-01)

Deep Learning Predicts Overall Survival of Patients With Unresectable Hepatocellular Carcinoma Treated by Transarterial Chemoembolization Plus Sorafenib
by: Lei Zhang, et al.
Published: (2020-09-01)

Transarterial Chemoembolization and Sorafenib Combined with Microwave Ablation for Advanced Primary Hepatocellular Carcinoma: A Preliminary Investigation of Safety and Efficacy
by: Ni JY, et al.
Published: (2019-11-01)

Radiological response in Saudi patients undergoing transarterial chemoembolization for hepatocellular carcinoma
by: Al Fuhaid Turki, et al.
Published: (2007-01-01)

A Rare Case of Empyema Developed after Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Young Keun Sur, et al.
Published: (2015-01-01)

Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractoriness
by: Tao Huang, et al.
Published: (2022-12-01)

Recent technical advances in conventional transarterial chemoembolization for hepatocellular carcinoma in Japan
by: Hiroki Higashihara, et al.
Published: (2021-10-01)

Transarterial Chemoembolization Combined With Hepatectomy for the Treatment of Intermediate-Stage Hepatocellular Carcinoma
by: Qunfang Zhou, et al.
Published: (2020-11-01)

Effects of Early TACE Refractoriness on Survival in Patients with Hepatocellular Carcinoma: A Real-World Study
by: Yang C, et al.
Published: (2022-07-01)

The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma
by: Fei-Xiang Wu, et al.
Published: (2017-09-01)

Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis
by: Lin Li, et al.
Published: (2018-09-01)

Comparing the effectiveness and safety of Sorafenib plus TACE with Apatinib plus TACE for treating patients with unresectable hepatocellular carcinoma: a multicentre propensity score matching study
by: Liang Yin, et al.
Published: (2023-05-01)

Beneficial Effect of Combining Radiotherapy and Transarterial Chemoembolization on Patient Survival in Hepatocellular Carcinomas and Macrovascular Invasion Treated with Sorafenib
by: Meng-Chuan Lu, et al.
Published: (2023-05-01)

Callispheres drug-eluting bead transhepatic artery chemoembolization with oral delivery of sorafenib for the treatment of unresectable liver cancer
by: Wenhui Wang, et al.
Published: (2022-09-01)

Efficacy and Safety of TACE Combined with Regorafenib Plus PD-1 Inhibitor in the Treatment of Hepatocellular Carcinoma After Sorafenib Resistance
by: Zou X, et al.
Published: (2023-02-01)

Diffuse Recurrence of Hepatocellular Carcinoma After Liver Resection: Transarterial Chemoembolization (TACE) Combined With Sorafenib Versus TACE Monotherapy
by: Wang Yao, et al.
Published: (2020-12-01)

Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma
by: Zhang W, et al.
Published: (2021-07-01)

Combination of Mac-2 Binding Protein Glycosylation Isomer and Up-To-Seven Criteria as a Useful Predictor for Child-Pugh Grade Deterioration after Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Yuji Eso, et al.
Published: (2019-03-01)

Impact of Low Muscle Mass on Hepatocellular Carcinoma Patients Undergoing Transcatheter Liver-Directed Therapies: Systematic Review & Meta-Analysis
by: Yen-Chun Chen, et al.
Published: (2024-01-01)